Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2025-12-25 @ 4:48 PM
Study NCT ID:
NCT01019603
Status:
COMPLETED
Last Update Posted:
2017-06-23
First Post:
2009-11-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris
Sponsor:
Stiefel, a GSK Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-10-12
Start Date Type:
ACTUAL
Primary Completion Date:
2009-12-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-12-20
Completion Date Type:
ACTUAL
First Submit Date:
2009-11-19
First Submit QC Date:
None
Study First Post Date:
2009-11-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-22
Last Update Post Date:
2017-06-23
Last Update Post Date Type:
ACTUAL